Neutralizing capacity of samples reactive to epitope 432–443 to genotype 2a HCVcc.

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

Fournier, Carole
Duverlie, Gilles
François, Catherine
Schnuriger, Aurélie
Dedeurwaerder, Sarah
Brochot, Etienne
Capron, Dominique
Wychowski, Czeslaw
Thibault, Vincent
Castelain, Sandrine

January 2007

Background/Aim. The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understo...

Neutralizing antibodies in 39 patients chronically infected with HCV, genotype 1, and treated with pegylated interferon/ribavirin.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

NAb50-titer for each plasma sample against each genotype 1a and genotype 1b recombinan...

Neutralizing antibodies in 26 patients chronically infected with hepatitis C virus, genotype 1a.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 26 patients with chronic HCV infection, genotype 1a, taken prior to treatment...

Neutralizing capacity of serum samples reactive to epitope 313–327 to genotype 2a HCVcc.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

HCVcc neutralization assays were performed in the presence of diluted 313–327 epitope-reactive sa...

Cross-genotype neutralizing capacity of 432–443 epitope-reactive human serum samples at the dilution 1/100.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

Six samples reactive to epitope 432–443 have cross-genotype neutralizing activity. Serum was asse...

Neutralizing activity of 432–443 epitope-reactive antibodies can be partially inhibited.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

Exogenous peptide in the presence of sera at a dilution resulting in approximately 50% inhibition...

Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313-327 and 432-443 of hepatitis C virus E1E2 glycoproteins.

Ruyu Liu
Huiying Rao
Jianghua Wang
Xingwang Xie
Dong Jiang
Xiaoben Pan
Ping Zhao
Henghui Zhang
Lai Wei

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313-327 and 432-443 of Hepatitis C Virus E1E2 Glycoproteins

Liu, Ruyu
Rao, Huiying
Wang, Jianghua
Xie, Xingwang
Jiang, Dong
Pan, Xiaoben
Zhao, Ping
Zhang, Henghui
Wei, Lai

January 2013

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–

Ping Zhao
Henghui Zhang
Lai Wei

August 2016

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Percentage of neutralization against genotype 1a and 1b culture viruses in 39 patients with chronic HCV, genotype 1, infection.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...

Determination of the human antibody response to the neutralization epitopes of glycoproteins E1E2 and its broad cross-genotype neutralizing activity in hepatitis C virus infection individuals

Ruyu Liu
Huiying Rao
Lai Wei

January 2012

Objective To determinate the prevalence of 5 neutralization epitope-binding antibodies and their cro...

Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus.

Chumbe, Ana
Urbanowicz, Richard A
Sliepen, Kwinten
Koekkoek, Sylvie M
Molenkamp, Richard
Tarr, Alexander W
Ball, Jonathan K
Schinkel, Janke
van Gils, Marit J

November 2022

A better understanding of the antibody response during natural infection and the effect on disease p...

Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a and 1b.

Soma Das (103160)
Rohini K. Shetty (103163)
Anuj Kumar (5797)
Radhika Nagamangalam Shridharan (103166)
Ranjitha Tatineni (103169)
Giriprakash Chi (103173)
Anirban Mukherjee (103177)
Saumitra Das (103180)
Shaila Melkote Subbarao (103183)
Anjali Anoop Karande (103188)

January 2013

Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a ...

Neutralizing antibodies in 39 patients chronically infected with hepatitis C virus, genotype 1.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...

Neutralizing activity of anti-E2 IgG and scFv antibodies against HCVcc infection.

Hiroshi Yokokawa (13844621)
Midori Shinohara (13844624)
Yuji Teraoka (4348378)
Michio Imamura (128656)
Noriko Nakamura (670459)
Noriyuki Watanabe (434683)
Tomoko Date (249626)
Hideki Aizaki (139942)
Tomokatsu Iwamura (13844627)
Hideki Narumi (13844630)
Kazuaki Chayama (128675)
Takaji Wakita (109321)

September 2022

The neutralization effects of anti-E2 antibodies were assessed using an infection system with chimer...

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

Fournier, Carole
Duverlie, Gilles
François, Catherine
Schnuriger, Aurélie
Dedeurwaerder, Sarah
Brochot, Etienne
Capron, Dominique
Wychowski, Czeslaw
Thibault, Vincent
Castelain, Sandrine

January 2007

Background/Aim. The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understo...

Neutralizing antibodies in 39 patients chronically infected with HCV, genotype 1, and treated with pegylated interferon/ribavirin.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

NAb50-titer for each plasma sample against each genotype 1a and genotype 1b recombinan...

Neutralizing antibodies in 26 patients chronically infected with hepatitis C virus, genotype 1a.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 26 patients with chronic HCV infection, genotype 1a, taken prior to treatment...

Neutralizing capacity of serum samples reactive to epitope 313–327 to genotype 2a HCVcc.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

HCVcc neutralization assays were performed in the presence of diluted 313–327 epitope-reactive sa...

Cross-genotype neutralizing capacity of 432–443 epitope-reactive human serum samples at the dilution 1/100.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

Six samples reactive to epitope 432–443 have cross-genotype neutralizing activity. Serum was asse...

Neutralizing activity of 432–443 epitope-reactive antibodies can be partially inhibited.

Ruyu Liu (426164)
Huiying Rao (159262)
Jianghua Wang (159271)
Xingwang Xie (426165)
Dong Jiang (159266)
Xiaoben Pan (426166)
Ping Zhao (47228)
Henghui Zhang (159258)
Lai Wei (36699)

June 2013

Exogenous peptide in the presence of sera at a dilution resulting in approximately 50% inhibition...

Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313-327 and 432-443 of hepatitis C virus E1E2 glycoproteins.

Ruyu Liu
Huiying Rao
Jianghua Wang
Xingwang Xie
Dong Jiang
Xiaoben Pan
Ping Zhao
Henghui Zhang
Lai Wei

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313-327 and 432-443 of Hepatitis C Virus E1E2 Glycoproteins

Liu, Ruyu
Rao, Huiying
Wang, Jianghua
Xie, Xingwang
Jiang, Dong
Pan, Xiaoben
Zhao, Ping
Zhang, Henghui
Wei, Lai

January 2013

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–

Ping Zhao
Henghui Zhang
Lai Wei

August 2016

It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potent...

Percentage of neutralization against genotype 1a and 1b culture viruses in 39 patients with chronic HCV, genotype 1, infection.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...

Determination of the human antibody response to the neutralization epitopes of glycoproteins E1E2 and its broad cross-genotype neutralizing activity in hepatitis C virus infection individuals

Ruyu Liu
Huiying Rao
Lai Wei

January 2012

Objective To determinate the prevalence of 5 neutralization epitope-binding antibodies and their cro...

Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus.

Chumbe, Ana
Urbanowicz, Richard A
Sliepen, Kwinten
Koekkoek, Sylvie M
Molenkamp, Richard
Tarr, Alexander W
Ball, Jonathan K
Schinkel, Janke
van Gils, Marit J

November 2022

A better understanding of the antibody response during natural infection and the effect on disease p...

Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a and 1b.

Soma Das (103160)
Rohini K. Shetty (103163)
Anuj Kumar (5797)
Radhika Nagamangalam Shridharan (103166)
Ranjitha Tatineni (103169)
Giriprakash Chi (103173)
Anirban Mukherjee (103177)
Saumitra Das (103180)
Shaila Melkote Subbarao (103183)
Anjali Anoop Karande (103188)

January 2013

Reactivities and epitope mapping of monoclonal antibodies (mAbs) against HCV-LPs of genotypes 3a ...

Neutralizing antibodies in 39 patients chronically infected with hepatitis C virus, genotype 1.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...

Neutralizing activity of anti-E2 IgG and scFv antibodies against HCVcc infection.

Hiroshi Yokokawa (13844621)
Midori Shinohara (13844624)
Yuji Teraoka (4348378)
Michio Imamura (128656)
Noriko Nakamura (670459)
Noriyuki Watanabe (434683)
Tomoko Date (249626)
Hideki Aizaki (139942)
Tomokatsu Iwamura (13844627)
Hideki Narumi (13844630)
Kazuaki Chayama (128675)
Takaji Wakita (109321)

September 2022

The neutralization effects of anti-E2 antibodies were assessed using an infection system with chimer...

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

Fournier, Carole
Duverlie, Gilles
François, Catherine
Schnuriger, Aurélie
Dedeurwaerder, Sarah
Brochot, Etienne
Capron, Dominique
Wychowski, Czeslaw
Thibault, Vincent
Castelain, Sandrine

January 2007

Background/Aim. The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understo...

Neutralizing antibodies in 39 patients chronically infected with HCV, genotype 1, and treated with pegylated interferon/ribavirin.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

NAb50-titer for each plasma sample against each genotype 1a and genotype 1b recombinan...

Neutralizing antibodies in 26 patients chronically infected with hepatitis C virus, genotype 1a.

Jannie Pedersen (410483)
Tanja B. Jensen (410484)
Thomas H. R. Carlsen (162324)
Kristian Schønning (410485)
Peer Brehm Christensen (213500)
Alex Lund Laursen (410486)
Henrik Krarup (213503)
Jens Bukh (162343)
Nina Weis (213509)

May 2013

Plasma samples from 26 patients with chronic HCV infection, genotype 1a, taken prior to treatment...

Neutralizing capacity of samples reactive to epitope 432–443 to genotype 2a HCVcc.

Abstract

Extracted data

Neutralizing capacity of samples reactive to epitope 432–443 to genotype 2a HCVcc.

Abstract

Extracted data

Related items

Related items